Latest news:
Suli Pharma’s new homepage begins to use since Oct. 2015.
APIs’ Intermediates
Intermediates of Acalabrutin...
Elagolix and Its Intermediat...
Dapagliflozin and Its Interm...
Canagliflozin and Its Interm...
Teneligliptin and Its Interm...
Intermediates of Apalutamide
Intermediate of Enzalutamide
Upadacitinib and Its Interme...
Filgotinib and Its Intermedi...
Baloxavir Marboxil and Its I...
Intermediates of Sofosbuvir
Intermediates of Ledipasvir
Intermediates of Daclatasvir
Intermediates of Tofacitinib
Velpatasvir intermediates
Intermediate of Indacaterol
Intermediates of Fondaparinu...
Intermediates of Lenalidomid...
Ribociclib’s intermediates
Abemaciclib’s Intermediate
Sacubitril-Valsartan (LCZ696...
Roxadustat and Intermediates
Tamsulosin intermediates
Empagliflozin and Intermedia...
Other Key Intermediates
Metal catalyst
Abemaciclib’s Intermediates
Number
Product name
CAS No.
Molecular formula
◇
4-[6-[[7-cyclopentyl-6-[(dimethylamino)carbonyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino]-3-pyridinyl]-1-Piperazinecarboxylic acid 1,1-dimethylethyl ester
1231930-37-2
◇
5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-amine
1180132-17-5
◇
6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
1231930-33-8
◇
6-(2-chloro-5-fluoropyrimidin-4-yl)-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole
1231930-42-9
About us
Company Introduction
Company news
Company culture
Organization
Certificates and Honors
Product Center
APIs’ Intermediates
Other Key Intermediates
Metal catalyst
Innovation and Facilities
Service and technologies
R&D; Facilities
Kilo-lab equipments
Facilities in plant
Analysis Instruments
QHSE
Quality
Health
Safety
Environment
Human Resource
Team Building
Training
Join Us
Copyright(C)2015, All Rights Reserved. Supported by
Copyright Notice